A group of researchers systematically reviewed previously published literature about psychological treatment in primary headache and its effectiveness. The results were published in The Journal of Headache and Pain.
Chronic headache, defined as headaches occurring more than 180 days per year, has been reported by the Eurolight Project to have a 1-year prevalence rate of 4.0% across Europe. In fact, according to the World Health Organization (WHO), migraine is the leading cause of global burden of disease in adults aged 15 to 49 years.
A group of researchers systematically reviewed previously published literature about psychological treatment in primary headache and its effectiveness. The results were published in The Journal of Headache and Pain.
The authors included 27 randomized clinical trials in their systematic review. The primary outcome was the number of headache days per month a patient would experience. Secondary outcomes included the number of headaches experienced by patients per week, headache index, treatment response rate, and migraine disability assessment.
Overall, the investigators found that psychological treatments showed “significant superiority,” over placebo (pooled mean difference = —0.70, 95% CI [–1.22, -0.18] P = .01) in terms of achieving primary outcomes. The authors also noted that, “According to type of headache, studies that restricted the sample to migraine significantly favored psychological treatment over placebo with pooled mean difference of —0.59 (95% CI [–1.12, –0.05]).”
Headache index was analyzed in 2 ways: mean difference of headache index score and proportion of those who responded to treatment. The pooled mean difference of change in headache index score was —0.92 (95% CI [–1.40, –0.44], P <.001), favoring the psychological treatment group over the control group. The study also found that treatment response was more prevalent in the psychological treatment arm than the control group, with a pooled response rate of 3.13 (95% CI [2.24, 4.37], P <.001). Though not statistically significant, results also showed that disability due to headache favored the psychological treatment group over the control group, as well.
In total, the results showed that psychological treatment reduced headache frequency and the suffering from headaches as measured by the headache index. Investigators recommend that psychological treatment can be safely considered as a possible option for the management of primary headache as a monotherapy for some patients, and in combination with other treatments in other patients.
Future studies should focus on “building more concrete evidence and making clearer recommendation,” as well as “standardiz[ing] outcome measures and strategies to reduce bias, such as pseudo-treatment for control groups,” the authors noted.
Reference
Jeong Lee H, Hyeok Lee J, Young Cho E, Mi Kim S, Yoon S. efficacy of psychological treatment for headache disorder: a systematic review and meta-analysis [published online February 14, 2019]. J Headache Pain. doi.org/10.1186/s10194-019-0965-4
Incorporating Discussions of Cannabis Use Into Oncology Care Visits
September 15th 2024The legalization of recreational marijuana in Minnesota has created daily conversations about how to incorporate the use of cannabis into treatment plans for patients with cancer, explained Marie Parish, PharmD, BCOP, of Mayo Clinic.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
How Can Digital Care Programs Aid Those With Chronic Musculoskeletal Pain?
June 9th 2020On this episode of Managed Care Cast, we speak with Jeffrey Krauss, MD, chief medical officer of Hinge Health and Stanford Clinical assistant professor, about the efficacy of a 12-week digital care program aimed to reduce lower back and knee pain in a real-world population.
Listen
Care for Migraine Insufficient in Germany, Online Survey Finds
March 25th 2022An online survey of migraineurs in Germany aimed to evaluate their most pressing unmet needs, with data collected on socioeconomic background, medical care experience, acute medication use, and migraine prophylaxis use and experience.
Read More